Canada expects to start receiving Johnson & Johnson COVID-19 vaccines next month

In a statement Johnson & Johnson said a batch of drug substance failed its quality test

In a statement Johnson & Johnson said a batch of drug substance failed its quality test

That process identified a batch that didn't meet standards at the Emergent site, which J&J noted has not yet been authorized. In a statement, J&J said it's working with federal authorities to deliver 24 million doses of the vaccine in April.

USA officials said the vaccine spoilage will not impact plans to provide enough vaccine to immunize every adult by May.

The Johnson & Johnson vaccine could be a game changer in the country's battle against COVID-19, as it only requires a single dose, unlike Pfizer, Moderna and AstraZeneca which each require a second dose to boost immunity. Federal officials attributed the mistake to human error.

In a statement provided to Fox Business, Johnson & Johnson said it expects to deliver its vaccine at a rate of more than one billion doses by the end of 2021.

A manufacturing mixup at a factory in Baltimore ruined about 15 million doses of the Johnson & Johnson coronavirus vaccine, The New York Times reported Wednesday. Only 3.3 million doses have been administered, CDC data show.

New York City police investigating two brutal assaults of Asians
The victim was taken to the NYU Langone Hospital with a fractured pelvis, and is reportedly in a stable condition. Scott Stringer, New York City's comptroller and mayoral candidate, called the attack "absolutely disgusting".

Emergent spotted the issue and notified the FDA, J&J said.

The J&J vaccine has been viewed as crucial for vaccination campaigns around the world, because only one shot is required and it can be shipped and stored at standard refrigeration temperatures, unlike some other vials that must be kept frozen.

Johnson & Johnson said it beat its March delivery target, providing the United States government more than 20 million doses, and that it expects to deliver another 24 million by the end of April. The company also has pledged to sell the vaccine without a profit, but only during the pandemic emergency.

The 27-nation European Union has signed a firm order for 200 million J&J doses and an option for 200 million more. The FDA said it was aware of the situation but declined further comment.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.